Profil
Sunitha Lakshminarayanan is Chief Technology Officer at Melinta Therapeutics, Inc. since 2024.
Former roles include Senior Vice President & Head-Product Development at Actinium Pharmaceuticals, Inc. from 2022 to 2024, and Executive Director-Cell Therapy Engineering at Bristol Myers Squibb Co. Education includes an MBA from Northwestern University, graduate studies at The Pennsylvania State University, and undergraduate studies at Coimbatore Institute of Technology.
Postes actifs de Sunitha Lakshminarayanan
| Sociétés | Poste | Début |
|---|---|---|
| MELINTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2024 |
Anciens postes connus de Sunitha Lakshminarayanan
| Sociétés | Poste | Fin |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2024 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formation de Sunitha Lakshminarayanan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coimbatore Institute of Technology
Coimbatore Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
















